Do analysts rate CANF or JAGX?

Can-Fite BioPharma presently has a consensus target price of $44.00, suggesting a potential upside of 1,270.72%. Given Can-Fite BioPharma's stronger consensus rating and higher probable upside, equities analysts plainly believe Can-Fite BioPharma is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Can-Fite BioPharma 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CANF or JAGX more profitable?

Can-Fite BioPharma has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Company Net Margins Return on Equity Return on Assets Can-Fite BioPharma N/A N/A N/A Jaguar Animal Health -169.04% N/A -115.55%

Do analysts prefer JAGX or ORGS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Orgenesis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is JAGX or ORGS more profitable?

Jaguar Animal Health has a net margin of -169.04% compared to Orgenesis' net margin of -3,827.81%. Company Net Margins Return on Equity Return on Assets Jaguar Animal Health -169.04% N/A -115.55% Orgenesis -3,827.81% N/A -130.18%

Do analysts recommend JAGX or BPTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bio-Path 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media refer more to ARTL or JAGX?

In the previous week, Artelo Biosciences and Artelo Biosciences both had 2 articles in the media. Artelo Biosciences' average media sentiment score of 0.00 equaled Jaguar Animal Health'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artelo Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jaguar Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate JAGX or CMND?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Jaguar Animal Health (JAGX) Competitors

$0.83 -0.12 (-12.18%)

Closing price 08/10/2026 04:00 PM Eastern

Extended Trading

$0.84 +0.00 (+0.07%)

As of 05:20 AM Eastern

Compare

JAGX vs. CANF, ORGS, BPTH, ARTL, and CMND

Should you buy Jaguar Animal Health stock or one of its competitors? Jaguar Animal Health's main competitors and comparable companies include Can-Fite BioPharma (CANF), Orgenesis (ORGS), Bio-Path (BPTH), Artelo Biosciences (ARTL), and Clearmind Medicine (CMND). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Jaguar Animal Health compare to Can-Fite BioPharma?

Can-Fite BioPharma (NYSE:CANF) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Can-Fite BioPharma has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%.

Company	Net Margins	Return on Equity	Return on Assets
Can-Fite BioPharma	N/A	N/A	N/A
Jaguar Animal Health	-169.04%	N/A	-115.55%

Can-Fite BioPharma has higher earnings, but lower revenue than Jaguar Animal Health. Can-Fite BioPharma is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Can-Fite BioPharma	$405K	5.19	-$7.63M	-$22.80	N/A
Jaguar Animal Health	$11.51M	0.04	-$53.43M	-$591.92	N/A

Can-Fite BioPharma has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market.

Can-Fite BioPharma presently has a consensus target price of $44.00, suggesting a potential upside of 1,270.72%. Given Can-Fite BioPharma's stronger consensus rating and higher probable upside, equities analysts plainly believe Can-Fite BioPharma is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Can-Fite BioPharma	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Jaguar Animal Health had 2 more articles in the media than Can-Fite BioPharma. MarketBeat recorded 2 mentions for Jaguar Animal Health and 0 mentions for Can-Fite BioPharma. Can-Fite BioPharma's average media sentiment score of 0.00 equaled Jaguar Animal Health'saverage media sentiment score.

Company	Overall Sentiment
Can-Fite BioPharma	Neutral
Jaguar Animal Health	Neutral

21.0% of Can-Fite BioPharma shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 0.8% of Can-Fite BioPharma shares are owned by company insiders. Comparatively, 0.2% of Jaguar Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Can-Fite BioPharma beats Jaguar Animal Health on 11 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to Orgenesis?

Jaguar Animal Health (NASDAQ:JAGX) and Orgenesis (NASDAQ:ORGS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, Jaguar Animal Health had 2 more articles in the media than Orgenesis. MarketBeat recorded 2 mentions for Jaguar Animal Health and 0 mentions for Orgenesis. Jaguar Animal Health's average media sentiment score of 0.00 equaled Orgenesis'average media sentiment score.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Orgenesis	Neutral

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 22.6% of Orgenesis shares are owned by institutional investors. 0.2% of Jaguar Animal Health shares are owned by insiders. Comparatively, 1.9% of Orgenesis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Jaguar Animal Health has higher revenue and earnings than Orgenesis. Orgenesis is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.04	-$53.43M	-$591.92	N/A
Orgenesis	$662K	2.73	-$55.36M	-$11.51	N/A

Jaguar Animal Health has a net margin of -169.04% compared to Orgenesis' net margin of -3,827.81%.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	N/A	-115.55%
Orgenesis	-3,827.81%	N/A	-130.18%

Jaguar Animal Health has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market. Comparatively, Orgenesis has a beta of 3.22, suggesting that its share price is 222% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Orgenesis	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Jaguar Animal Health beats Orgenesis on 7 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Bio-Path?

Jaguar Animal Health (NASDAQ:JAGX) and Bio-Path (NASDAQ:BPTH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

Jaguar Animal Health has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market. Comparatively, Bio-Path has a beta of -0.51, suggesting that its share price is 151% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bio-Path	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 5.7% of Bio-Path shares are owned by institutional investors. 0.2% of Jaguar Animal Health shares are owned by insiders. Comparatively, 0.7% of Bio-Path shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Bio-Path has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat Bio-Path's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	N/A	-115.55%
Bio-Path	N/A	-2,842.40%	-337.48%

In the previous week, Jaguar Animal Health had 2 more articles in the media than Bio-Path. MarketBeat recorded 2 mentions for Jaguar Animal Health and 0 mentions for Bio-Path. Jaguar Animal Health's average media sentiment score of 0.00 equaled Bio-Path'saverage media sentiment score.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Bio-Path	Neutral

Bio-Path has lower revenue, but higher earnings than Jaguar Animal Health. Bio-Path is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.04	-$53.43M	-$591.92	N/A
Bio-Path	N/A	N/A	-$16.08M	-$1.09	N/A

Summary

Jaguar Animal Health beats Bio-Path on 8 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Artelo Biosciences?

Artelo Biosciences (NASDAQ:ARTL) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

Artelo Biosciences has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market.

In the previous week, Artelo Biosciences and Artelo Biosciences both had 2 articles in the media. Artelo Biosciences' average media sentiment score of 0.00 equaled Jaguar Animal Health'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artelo Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

0.9% of Artelo Biosciences shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 3.2% of Artelo Biosciences shares are held by company insiders. Comparatively, 0.2% of Jaguar Animal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Artelo Biosciences has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat Artelo Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artelo Biosciences	N/A	-1,600.12%	-224.62%
Jaguar Animal Health	-169.04%	N/A	-115.55%

Artelo Biosciences has higher earnings, but lower revenue than Jaguar Animal Health. Artelo Biosciences is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artelo Biosciences	N/A	N/A	-$12.88M	-$32.74	N/A
Jaguar Animal Health	$11.51M	0.04	-$53.43M	-$591.92	N/A

Artelo Biosciences currently has a consensus price target of $54.00, suggesting a potential upside of 7,558.49%. Given Artelo Biosciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Artelo Biosciences is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artelo Biosciences	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Artelo Biosciences and Jaguar Animal Health tied by winning 6 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Clearmind Medicine?

Jaguar Animal Health (NASDAQ:JAGX) and Clearmind Medicine (NASDAQ:CMND) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Clearmind Medicine has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Jaguar Animal Health's return on equity of 0.00% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	N/A	-115.55%
Clearmind Medicine	N/A	-143.79%	-88.51%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 0.2% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Jaguar Animal Health has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market. Comparatively, Clearmind Medicine has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market.

Clearmind Medicine has lower revenue, but higher earnings than Jaguar Animal Health. Clearmind Medicine is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.04	-$53.43M	-$591.92	N/A
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A

In the previous week, Jaguar Animal Health had 2 more articles in the media than Clearmind Medicine. MarketBeat recorded 2 mentions for Jaguar Animal Health and 0 mentions for Clearmind Medicine. Clearmind Medicine's average media sentiment score of 0.26 beat Jaguar Animal Health's score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Clearmind Medicine	Neutral

Summary

Clearmind Medicine beats Jaguar Animal Health on 7 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$570K	$11.81B	$7.01B	$12.98B
Dividend Yield	N/A	2.69%	2.58%	10.07%
P/E Ratio	0.00	788.51	269.18	24.72
Price / Sales	0.04	747.68	589.72	98.19
Price / Cash	N/A	15.12	28.89	37.42
Price / Book	-0.01	10.28	11.34	6.42
Net Income	-$53.43M	$2.77B	$3.45B	$347.03M
7 Day Performance	-16.56%	0.86%	1.94%	0.71%
1 Month Performance	-63.88%	-1.58%	-0.56%	-0.87%
1 Year Performance	-98.90%	183.20%	75.50%	21.94%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.397 of 5 stars	$0.83 -12.2%	N/A	-98.9%	$570K	$11.51M	N/A	50	Upcoming Earnings Gap Up High Trading Volume
CANF Can-Fite BioPharma	1.7147 of 5 stars	$3.19 +0.6%	$44.00 +1,279.3%	-76.6%	$2.09M	$405K	N/A	8
ORGS Orgenesis	N/A	$0.40 +33.3%	N/A	-60.7%	$2.07M	$662K	N/A	150	Gap Up
BPTH Bio-Path	N/A	$0.04 flat	N/A	-73.3%	$1.91M	N/A	N/A	10	Upcoming Earnings
ARTL Artelo Biosciences	1.6475 of 5 stars	$0.77 +3.0%	$54.00 +6,957.9%	-97.2%	$1.73M	N/A	N/A	5	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. CANF, ORGS, BPTH, ARTL, and CMND

How does Jaguar Animal Health compare to Can-Fite BioPharma?

Summary

How does Jaguar Animal Health compare to Orgenesis?

Summary

How does Jaguar Animal Health compare to Bio-Path?

Summary

How does Jaguar Animal Health compare to Artelo Biosciences?

Summary

How does Jaguar Animal Health compare to Clearmind Medicine?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. CANF, ORGS, BPTH, ARTL, and CMND

How does Jaguar Animal Health compare to Can-Fite BioPharma?

Is CANF or JAGX more profitable?

Which has stronger earnings & valuation, CANF or JAGX?

Which has more volatility & risk, CANF or JAGX?

Do analysts rate CANF or JAGX?

Does the media prefer CANF or JAGX?

Do insiders & institutionals hold more shares of CANF or JAGX?

Summary

How does Jaguar Animal Health compare to Orgenesis?

Does the media favor JAGX or ORGS?

Do institutionals and insiders have more ownership in JAGX or ORGS?

Which has stronger earnings & valuation, JAGX or ORGS?

Is JAGX or ORGS more profitable?

Which has more risk & volatility, JAGX or ORGS?

Do analysts prefer JAGX or ORGS?

Summary

How does Jaguar Animal Health compare to Bio-Path?

Which has more risk and volatility, JAGX or BPTH?

Do analysts recommend JAGX or BPTH?

Do insiders and institutionals have more ownership in JAGX or BPTH?

Is JAGX or BPTH more profitable?

Does the media prefer JAGX or BPTH?

Which has higher earnings and valuation, JAGX or BPTH?

Summary

How does Jaguar Animal Health compare to Artelo Biosciences?

Which has more volatility and risk, ARTL or JAGX?

Does the media refer more to ARTL or JAGX?

Do insiders & institutionals hold more shares of ARTL or JAGX?

Is ARTL or JAGX more profitable?

Which has higher valuation and earnings, ARTL or JAGX?

Do analysts rate ARTL or JAGX?

Summary

How does Jaguar Animal Health compare to Clearmind Medicine?

Is JAGX or CMND more profitable?

Do analysts rate JAGX or CMND?

Do institutionals & insiders hold more shares of JAGX or CMND?

Which has more volatility & risk, JAGX or CMND?

Which has stronger valuation & earnings, JAGX or CMND?

Does the media prefer JAGX or CMND?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools